A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein.
about
Screening of FDA-Approved Drugs for Inhibitors against Japanese Encephalitis Virus Infection.Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists.Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.
P2860
A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A Novel Benzodiazepine Compoun ...... ically Targeting NS4B Protein.
@en
A Novel Benzodiazepine Compoun ...... ically Targeting NS4B Protein.
@nl
type
label
A Novel Benzodiazepine Compoun ...... ically Targeting NS4B Protein.
@en
A Novel Benzodiazepine Compoun ...... ically Targeting NS4B Protein.
@nl
altLabel
A Novel Benzodiazepine Compoun ...... fically Targeting NS4B Protein
@en
prefLabel
A Novel Benzodiazepine Compoun ...... ically Targeting NS4B Protein.
@en
A Novel Benzodiazepine Compoun ...... ically Targeting NS4B Protein.
@nl
P2093
P2860
P356
P1433
P1476
A Novel Benzodiazepine Compoun ...... fically Targeting NS4B Protein
@en
P2093
Andrea Cuconati
Jinhong Chang
Ju-Tao Guo
Justin Julander
Timothy M Block
Xuexiang Zhang
Yanming Du
P2860
P304
10774-10788
P356
10.1128/JVI.01253-16
P407
P50
P577
2016-11-14T00:00:00Z